Optimization of Alcohol Dehydrogenase for Industrial Scale Oxidation of Lactols.
Sebastian BartschJan BrummundSabrina KöpkeHarrie StraatmanAndreas VogelMartin SchürmannPublished in: Biotechnology journal (2020)
Alcohol dehydrogenases (ADH) are widely used to enantioselectively reduce ketones to chiral alcohols, but their application in industrial scale oxidations is rare. Reasons are the need for an NAD(P)+ cofactor regeneration system, often low performance in oxidative reactions and the limited substrate scope of ADHs. ADHA from Candida magnoliae DSMZ 70638 is identified to efficiently catalyze the regio-selective hydroxy-lactone oxidations to hydroxy-lactones. Hydroxy-lactones are common intermediates in industrial processes to cholesterol lowering (va)statin drugs. A biocatalytic aliphatic hydroxy-lactone oxidation process is developed using pure oxygen as oxidant reaching volumetric productivities of up to 12 g L-1 h-1 , product concentrations of almost 50 g L-1 and 95% reaction yield. For co-factor recycling a previously engineered, water-forming NAD(P)H-oxidase from Streptococcus mutans is used. The process is scaled up to industrial pilot plant scale and it could be demonstrated that ADH catalyzed oxidations can be developed to efficient and safe processes. However, the ADHA wild-type enzyme is not productive enough in chlorolactol oxidation. Therefore, enzyme engineering and multi-parameter screening is successfully applied to optimize the enzyme for the target reaction. The optimized ADHA variant shows a 17-fold higher oxidative activity, a 26°C increased stability and is applied to develop an efficient chlorolactol oxidation process.
Keyphrases
- wastewater treatment
- heavy metals
- hydrogen peroxide
- candida albicans
- electron transfer
- biofilm formation
- wild type
- stem cells
- coronary artery disease
- alcohol consumption
- cardiovascular disease
- risk assessment
- visible light
- clinical trial
- pseudomonas aeruginosa
- low density lipoprotein
- staphylococcus aureus
- type diabetes
- randomized controlled trial
- mass spectrometry